My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 118

    1.

    Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.

    Yki-Järvinen H, Juurinen L, Alvarsson M, Bystedt T, Caldwell I, Davies M, Lahdenperä S, Nijpels G, Vähätalo M.

    Diabetes Care. 2007 Jun;30(6):1364-9. Epub 2007 Mar 23.PMID: 17384341 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    3.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    4.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

    Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team.

    Diabetes Care. 2006 Jan;29(1):1-8.PMID: 16373887 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.

    Riddle M, Frias J, Zhang B, Maier H, Brown C, Lutz K, Kolterman O.

    Diabetes Care. 2007 Nov;30(11):2794-9. Epub 2007 Aug 13.PMID: 17698615 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dosing of insulin glargine in the treatment of type 2 diabetes.

    Barnett A.

    Clin Ther. 2007 Jun;29(6):987-99. Review.PMID: 17692716 [PubMed - indexed for MEDLINE]Related articles

    8.

    Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.

    Harris S, Yale JF, Dempsey E, Gerstein H.

    Can Fam Physician. 2008 Apr;54(4):550-8.PMID: 18411384 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program.

    Philis-Tsimikas A, Zhang Q, Walker C.

    Am J Ther. 2006 Nov-Dec;13(6):466-72.PMID: 17122525 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen]

    Bu S, Guo XH, Yang WY, Lu GZ, Yang ZJ, Ren TT, Gao Y.

    Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3115-8. Chinese. PMID: 18269868 [PubMed - indexed for MEDLINE]Related articles

    11.

    Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents.

    Davis SN, Johns D, Maggs D, Xu H, Northrup JH, Brodows RG.

    Diabetes Care. 2007 Nov;30(11):2767-72. Epub 2007 Jun 26.PMID: 17595353 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.

    Hollander P, Yu D, Chou HS.

    Arch Intern Med. 2007 Jun 25;167(12):1284-90.PMID: 17592102 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.

    Loipl J, Schmekal B, Biesenbach G.

    Ren Fail. 2005;27(3):305-8.PMID: 15957547 [PubMed - indexed for MEDLINE]Related articles

    14.

    Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs.

    Papa G, Fedele V, Chiavetta A, Lorenti I, Leotta C, Luca S, Rabuazzo AM, Piro S, Alagona C, Spadaro L, Purrello F, Pezzino V.

    Acta Diabetol. 2008 Mar;45(1):53-9. Epub 2008 Jan 8.PMID: 18180864 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies.

    Davies M, Sinnassamy P, Storms F, Gomis R; AT.LANTUS Study Group.

    Diabetes Res Clin Pract. 2008 Feb;79(2):368-75. Epub 2007 Nov 5.PMID: 17980928 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

    Lewin A, Lipetz R, Wu J, Schwartz S.

    Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight.

    Karl D, Philis-Tsimikas A, Darsow T, Lorenzi G, Kellmeyer T, Lutz K, Wang Y, Frias JP.

    Diabetes Technol Ther. 2007 Apr;9(2):191-9.PMID: 17425446 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.

    Zinman B, Hoogwerf BJ, Durán García S, Milton DR, Giaconia JM, Kim DD, Trautmann ME, Brodows RG.

    Ann Intern Med. 2007 Apr 3;146(7):477-85. Erratum in: Ann Intern Med. 2007 Jun 19;146(12):896. PMID: 17404349 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glycemic response to newly initiated diabetes therapies.

    Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Go AS, Selby JV.

    Am J Manag Care. 2007 Nov;13(11):598-606.PMID: 17988185 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity